- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT04830007
Factors Associated With the Absence of Contraception at Women Seeking a Voluntary Termination of Pregnancy
Factors Associated With the Absence of Contraception at the Time of Unplaned Pregnancy Among Women Seeking a Voluntary Termination of Pregnancy
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
In 1967, the Neuwirth law allowed women to control their fertility by establishing the right to contraception as a principle. Since then, they have continued to take ownership of the various contraceptive methods, which are regularly renewed.
Contraceptive coverage is important in France as it is estimated that 92% of women of childbearing age use a contraceptive method. The pill remains the most widely used method of contraception (36.5%), ahead of the intrauterine device (25.6%) condoms (15.5%) Several laws have been introduced from 1967 to today to facilitate access to sexual health care: screening for sexually transmitted infections, free provision of emergency contraception to minors, non-prescription delivery of emergency contraception, free consultation at a family planning and education center, voluntary termination of pregnancy 100%, reimbursement of condoms by social security.
Despite all the measures put in place, it is now clear that the number of unplanted pregnancies is decreasing slightly and the number of abortion has remained stable since 2001.
According to the latest literature data, several socio-demographic factors appear to play a role in the rate of use of voluntary termination of pregnancy., including age, socio-cultural level, marital and economic status and ethnic origin. All the more striking, it appears that while voluntary termination of pregnancy are mainly related to contraceptive failures, one third of them involve women who do not have contraception. According to the latest Ined survey, and in accordance with other data from the literature, the factors associated with the absence of contraceptive use are multiple: ignorance about fertility, family or cultural context, cost of contraceptive methods or lack of information related to them.
While these studies have looked at the reasons given by women for the lack of contraception, with little data on the characteristics of these women, particularly socio-demographics and their reproductive history and in particular in the context of unwanted pregnancy. This finding leads us to question the factors associated with the absence of contraception among women in demand of a voluntary termination of pregnancy.
Tipo di studio
Iscrizione (Anticipato)
Contatti e Sedi
Luoghi di studio
-
-
-
Villeneuve-Saint-Georges, Francia
- CHI Villeneuve St Georges
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- woman of 18 years of age or older;
- Being French-speaking;
- request for a medical or instrumental voluntary termination of pregnancy
- No opposition to participation in the protocol
- Be affiliated with a social security plan
Exclusion Criteria:
- desired pregnancy
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Association between absence of contraception and socio-demographic factors, characteristics of pregnancy abortion and medical follow-up
Lasso di tempo: 1 hour
|
Statistically significant association between the absence of contraception in patients consulting for a voluntary termination of pregnancy and socio-demographic factors, characteristics of voluntary termination of pregnancy abortion and characteristics related to medical follow-up
|
1 hour
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Prescription and dispensing of contraception
Lasso di tempo: 1 hour
|
Prevalence of patients informed about the prescription and dispensing of contraception including emergency contraception
|
1 hour
|
|
Existence of family planning centers
Lasso di tempo: 1 hour
|
Prevalence of patients informed about the existence of family planning centers
|
1 hour
|
|
Emergency contraception
Lasso di tempo: 1 hour
|
Prevalence of women who have used emergency contraception
|
1 hour
|
|
Price and reimbursement of condoms
Lasso di tempo: 1 hour
|
Prevalence of women informed about the price and reimbursement of condoms
|
1 hour
|
|
Knowledge of conception
Lasso di tempo: 1 hour
|
Estimate the percentage of women who thought they could get pregnant at the time of the intercourse that led to this pregnancy
|
1 hour
|
|
Fertile window
Lasso di tempo: 1 hour
|
Prevalence of women who use a method to track their fertile window
|
1 hour
|
|
Affection of fertility
Lasso di tempo: 1 hour
|
Estimate the percentage of women who think that contraception can affect their fertility
|
1 hour
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio (Anticipato)
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- NOCONTRAIVG
- 2021-A00298-33 (Altro identificatore: ID-RCB)
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .